Ticagrelor 90Mg Tablet

DRUG2 trials

Sponsors

The Guthrie Clinic, East and North Hertfordshire NHS Trust

Conditions

Acute Coronary SyndromePercutaneous Coronary Intervention

Phase 4

Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention

TerminatedNCT03476369

The Guthrie ClinicPercutaneous Coronary Intervention

Start: 2018-04-18End: 2025-01-23Updated: 2026-02-04

Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS

East and North Hertfordshire NHS TrustAcute Coronary Syndrome

Start: 2019-01-08End: 2021-12-31Target: 150Updated: 2020-02-12

Related Papers

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome.

2020-02-015 citations